Detailed Information on Publication Record
2022
Phosphorylated and Phosphomimicking Variants May Differ—A Case Study of 14-3-3 Protein
KOZELEKOVÁ, Aneta, Alexandra NÁPLAVOVÁ, Tomáš BROM, Norbert GAŠPARIK, Jan ŠIMEK et. al.Basic information
Original name
Phosphorylated and Phosphomimicking Variants May Differ—A Case Study of 14-3-3 Protein
Authors
KOZELEKOVÁ, Aneta (203 Czech Republic, belonging to the institution), Alexandra NÁPLAVOVÁ (203 Czech Republic, belonging to the institution), Tomáš BROM (203 Czech Republic, belonging to the institution), Norbert GAŠPARIK (703 Slovakia, belonging to the institution), Jan ŠIMEK (203 Czech Republic, belonging to the institution), Josef HOUSER (203 Czech Republic, belonging to the institution) and Jozef HRITZ (703 Slovakia, guarantor, belonging to the institution)
Edition
Frontiers in Chemistry, Frontiers Media SA, 2022, 2296-2646
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.500
RIV identification code
RIV/00216224:14740/22:00119696
Organization unit
Central European Institute of Technology
UT WoS
000777334200001
Keywords in English
14-3-3; phosphorylation; phosphomimicking mutation; oligomeric state; dissociation constant
Tags
International impact, Reviewed
Změněno: 27/10/2024 15:22, Ing. Martina Blahová
Abstract
V originále
Protein phosphorylation is a critical mechanism that biology uses to govern cellular processes. To study the impact of phosphorylation on protein properties, a fully and specifically phosphorylated sample is required although not always achievable. Commonly, this issue is overcome by installing phosphomimicking mutations at the desired site of phosphorylation. 14-3-3 proteins are regulatory protein hubs that interact with hundreds of phosphorylated proteins and modulate their structure and activity. 14-3-3 protein function relies on its dimeric nature, which is controlled by Ser58 phosphorylation. However, incomplete Ser58 phosphorylation has obstructed the detailed study of its effect so far. In the present study, we describe the full and specific phosphorylation of 14-3-3ζ protein at Ser58 and we compare its characteristics with phosphomimicking mutants that have been used in the past (S58E/D). Our results show that in case of the 14-3-3 proteins, phosphomimicking mutations are not a sufficient replacement for phosphorylation. At physiological concentrations of 14-3-3ζ protein, the dimer-monomer equilibrium of phosphorylated protein is much more shifted towards monomers than that of the phosphomimicking mutants. The oligomeric state also influences protein properties such as thermodynamic stability and hydrophobicity. Moreover, phosphorylation changes the localization of 14-3-3ζ in HeLa and U251 human cancer cells. In summary, our study highlights that phosphomimicking mutations may not faithfully represent the effects of phosphorylation on the protein structure and function and that their use should be justified by comparing to the genuinely phosphorylated counterpart.
Links
EF18_046/0015974, research and development project |
| ||
GF20-05789L, research and development project |
| ||
MUNI/C/1562/2019, interní kód MU |
| ||
90127, large research infrastructures |
| ||
90129, large research infrastructures |
|